Published 11/05/2009 by Pharmaceutical Executive
J&J Cuts Staff in Major Restructuring Move
Company CEO William Weldon told investors that the cuts are being made primarily to ensure that J&J can fund the myriad of drugs and product it has coming down the pipe. Not surprisingly, management is blaming the economy for the brunt of the layoffs. When you look at the...
Share this
There are no more reports on this story yet.